| 000 | 01213 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250512012152.0 | ||
| 264 | 0 | _c19890420 | |
| 008 | 198904s 0 0 eng d | ||
| 022 | _a0360-3997 | ||
| 024 | 7 |
_a10.1007/BF00918960 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDubose, D A | |
| 245 | 0 | 0 |
_aModulation of phospholipase A2 lytic activity by actin and myosin. _h[electronic resource] |
| 260 |
_bInflammation _cFeb 1989 |
||
| 300 |
_a15-29 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aActins _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Adhesion |
| 650 | 0 | 4 |
_aCytoskeleton _xdrug effects |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xcytology |
| 650 | 0 | 4 |
_aEpoprostenol _xbiosynthesis |
| 650 | 0 | 4 |
_aHemolysis _xdrug effects |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aMyosins _xpharmacology |
| 650 | 0 | 4 |
_aPhospholipases _xmetabolism |
| 650 | 0 | 4 |
_aPhospholipases A _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPhospholipases A2 |
| 650 | 0 | 4 | _aRats |
| 700 | 1 | _aShepro, D | |
| 700 | 1 | _aHechtman, H B | |
| 773 | 0 |
_tInflammation _gvol. 13 _gno. 1 _gp. 15-29 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00918960 _zAvailable from publisher's website |
| 999 |
_c2652111 _d2652111 |
||